Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2314-2026

Allia IGS 3 Pulse angiographic X-ray system Recall

Allia IGS 3 Pulse angiographic X-ray system

FDA recall Class II

Ongoing

FDA lists this Class II recall for Allia IGS 3 Pulse angiographic X-ray system. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2314-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 20, 2026
FDA report date
Jun 17, 2026
Quantity in commerce
9 units
Distribution
See key details
FDA cause
Device Design

What is being recalled?

Allia IGS 3 Pulse angiographic X-ray system

Affected model & UDI checker

Search the exact identifiers published for Z-2314-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedAllia IGS 3 Pulse angiographic X-ray systemCheck source notice00195278719577
FDA code information

UDI-DI: 00195278719577; Serial Numbers: M3-24-053, M3-24-124, M3-25-029, M3-25-051, M3-25-053, M3-25-091, M3-25-098, M3-25-124, M3-26-010, M3-26-030

View the original FDA recall notice

Why was this product recalled?

GE HealthCare has become aware of a potential issue affecting an electrical cable on certain IGS systems equipped with Gaia generators. This issue could lead to a risk of electrical shock to service personnel performing installation, maintenance, or troubleshooting activities inside the C-FRT cabinet while power is ON.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did GE Medical Systems, LLC take?

An URGENT MEDICAL DEVICE CORRECTION dated 4/20/26 was sent to customers. Actions to be taken by Customer/User You can continue to use your system. As a reminder, qualified service personnel must follow the Service Manual applicable to your system and use the appropriate personal protective equipment (PPE) for electrical hazards when performing any activity inside the cabinet while power is ON. If any abnormal condition is observed on the Iris Power Cable during servicing, such as loose or visibly exposed wires, qualified service personnel must follow the Electrical Lockout/Tagout Procedure as described in Service Manual. Please ensure that all potential users and service personnel in your facility are made aware of this safety notification and the recommended actions and post this letter in a visible location near the C-FRT cabinet. Please retain this document for your records. Please complete and return the attached acknowledgement form electronically via FMI 18014 Digital Response Form or print, fill out manually, scan, and email to recall.18014@gehealthcare.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology